New member | IRICE
Jeanne Chamousset-Roman is Consultant in Regulatory Affairs and Quality Management in MEDICAL DEVICES supporting companies for various procedures: Regulatory... View Article
Valneva in Advanced Discussions with European Commission to Supply up to 60 Million Doses of Inactivated, Adjuvanted COVID-19 Vaccine Candidate
Valneva, a specialty vaccine company focused on prevention of infectious diseases with significant unmet medical need, today announced it is... View Article
Valneva Reports FY 2020 Cash of Over €200 Million
FY 2020 cash and cash equivalents of €204.4 million, exceeding guidance of between €180 million and €200 million. FY 2020... View Article
New member | MAD-UP
MAD-UP specializes in the development of technological solutions for the health care of musculoskeletal disorders. Its intelligent dynamic compression solution... View Article
OSE Immunotherapeutics Announces Enrolment of First Patient with Ulcerative Colitis in Phase 2 Trial Testing Anti-IL-7 Receptor Antagonist OSE-127/S95011
OSE Immunotherapeutics today announced enrolment of the first patient in its Phase 2 clinical trial evaluating the benefits of anti-IL-7... View Article
OSE Immunotherapeutics Receives €5.2 M in Public Funding for the Clinical Development of CoVepiT, its Second Generation COVID-19 Vaccine
• CoVepiT demonstrated generation of sentinel memory T cells with long-term protective effect against COVID-19 in preclinical and human ex... View Article
Valneva Initiates Phase 1/2 Clinical Study of Inactivated, Adjuvanted COVID-19 Vaccine Candidate
Valneva SE, a specialty vaccine company focused on prevention against diseases with major unmet needs, today announced the initiation of... View Article
New member | Substra Foundation
Substra Foundation is an independent nonprofit organization dedicated to fostering the development of trustworthy data science ecosystems. It promotes, protects... View Article
BHealthCare raises € 1.5 M to finalise development of its robotic blood sampling platform, HEIVA™
BHealthCare, a MedTech specialising in the development of next-generation robotic solutions to provide more reliable peripheral vascular access, has announced... View Article
The “France Relance” stimulus package: the Healthcare Clusters network proposes three options to guarantee French healthcare sovereignty
Improve access to equity by launching novel specialised investment funds Support research and innovation by issuing calls for projects with... View Article